Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03702725 |
|---|---|
| Brief Title: | Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma |
| First Submitted : | August 31, 2018 |
| First Submitted that Met QC Criteria : | October 9, 2018 |
| First Posted : | October 11, 2018 |
| Last Update Submitted that Met QC Criteria : | January 4, 2024 |
| Last Update Posted : | January 8, 2024 |